Prognos Health

Breast cancer treatment is constantly evolving. To ensure the right patients receive the right therapies at the right time, we need to understand the patient journey and engage with healthcare professionals (HCPs) effectively. Lab data is key! It provides valuable insights that can be used to: - Identify the specific type and stage of cancer - Understand patient response to different therapies - Develop targeted drug development and personalized treatment strategies - Create more effective marketing campaigns Want to learn more about how lab data can improve breast cancer treatment? Read our latest blog post: https://bit.ly/4dnTkV1 #breastcancer #breastcancertreatment #labdata #HCPengagement #patientjourney

Are you a commercial leader or brand marketer based in Boston and focused on rare disease and/or oncology? Join Prognos Health for an exclusive half-day event on Tuesday, October 15th, 2024 in Boston to learn how to leverage real-world lab data for faster, more precise HCP identification and engagement. 💡 Gain insights from a panel of industry experts on: - Identifying and engaging HCPs treating complex patient populations - Better leveraging real-world data to optimize HCP targeting - Accelerating commercial launches in rare disease, oncology, and other complex clinical populations 🥂 Network with colleagues over cocktails and appetizers after the session. Space is limited! 👉 Register now: https://bit.ly/3MEgziX #HCPengagement #raredisease #oncology #realworlddata

Just a few more days until Digital Pharma East 2024! The Prognos team would love to connect and share more about our new offerings in rare disease, oncology, and media. Drop by booth K1 or book a time to connect here: https://bit.ly/3XAfcIo Christopher N. Hayes, Andrew Mataraso, Steven Vitale, and Jim Dietz look forward to seeing you there! #dpeast #rwd #healthcareinnovation

Check out our latest press release: https://bit.ly/4fPfWjV In the fast-paced world of healthcare, especially for rare diseases and oncology, every second counts. Prognos Health is thrilled to announce its groundbreaking daily HCP alerts solution. This innovative solution empowers pharmaceutical companies to engage with healthcare providers (HCPs) precisely when critical treatment decisions are being made. 🚀 Key Benefits: * Timely: Delivered within 48 hours of a patient event * Precise: Target clinically complex patient populations using lab and claims data * Actionable: Focus on specialists actively managing and treating patients 💡 Perfect for oncology, rare diseases, and other complex clinical areas where timely intervention is critical. "Our daily alerts leverage unique lab-based datasets to accelerate interventions, ensuring patients receive the most targeted and effective therapies sooner," says Dr. Jason Bhan, Chief Medical Officer at Prognos Health. 🎯 Rollout begins October 1st! #PrognosHealth #HCPalerts #PrecisionMedicine #Oncology #RareDisease #HealthcareInnovation

It may not be Rare Disease Day, but 30 million Americans living with one of 7,000+ rare conditions are impacted every day. Less than 5% have treatment options. Prognos Health's data sets offers a solution to accelerate change: - Identify high-potential targets and precise patient cohorts - Target HCPs serving rare disease patients to ensure therapy awareness - Demonstrate real-world value to support more successful commercial launches Time is precious for patients with rare diseases. Contact us today to discover how Prognos Health's unique, harmonized, and enriched lab data sets can make a difference: https://bit.ly/3yDm5yG #rwd #raredisease #HCPengagement #PrognosHealth #unlocklabdata

Check out the latest on the relevance of lab data as part of a real-world data strategy in a recent collaboration with our Chief Medical Officer, Jason Bhan, MD and Datavant. Download the full ebook here: https://hubs.ly/Q02KpGC20 #rwd #labdata #patientoutcomes

Tired of duplicate patient alerts, limited geographic reach, and messy lab data hindering your HCP engagement efforts? Our latest blog post delves into these common challenges and explores how a strategic approach to patient alerts can transform your strategy: * Optimize resource allocation by eliminating redundant alerts * Expand your reach to engage HCPs nationwide * Ensure data accuracy for targeted, effective communication * Improve timing to influence treatment decisions at critical moments There's a better way to engage HCPs and drive your brand's success. Read more here: https://bit.ly/3WtalGV #HCPengagement #pharmaceuticalmarketing #patientalerts #datadrivenmarketing #PrognosAlerts

The DOJ's recent ruling on sponsored genetic testing has major implications for rare disease pharma. What does it mean for patient identification and research efforts? Our new blog post from General Counsel and Chief Privacy Officer Hilary Weckstein breaks down: - Key takeaways from the DOJ's decision - Why real-world data (RWD) is now essential for rare disease companies - How harmonized lab data can revolutionize HCP and patient identification Read the full post here: https://bit.ly/3Yr2yvT Stay ahead of the curve. Learn how RWD and lab data can drive your success in this evolving regulatory landscape. #raredisease #pharma #biotech #RWD #healthdata

While we know it's still summer, we are looking forward to sponsoring Digital Pharma East in Philadelphia September 9-12, 2024. Christopher N. Hayes Andrew Mataraso and Jim Dietz would love to connect and share more about our precision marketing solutions for commercial teams focused on rare disease and oncology. Drop by Booth K1 or book time on our team's calendar: https://bit.ly/3WB7nRY #DPEast #RWD #raredisease #oncology

The landscape of NSCLC treatment is evolving rapidly, and personalized medicine is at the forefront. Our latest blog post dives into a massive dataset of 80,000+ ALK, 35,000+ ROS1, 11,000+ EGFR, and more FISH results, shedding light on the prevalence of key mutations and the potential for more precise treatment plans. For pharmaceutical companies seeking to target clinicians and patients effectively, this data is a game-changer. Learn how these insights can revolutionize NSCLC care: https://bit.ly/3SkGEGT #NSCLC #PersonalizedMedicine #RealWorldData #PrognosHealth